SciELO - Scientific Electronic Library Online

 
vol.34 issue7Management of Quality in an Intensive Care Unit: Implementation of ISO 9001:2008 international standard author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Medicina Intensiva

Print version ISSN 0210-5691

Abstract

OLIVERA-GONZALEZ, S. et al. Metformin-associated hepatotoxicity. Med. Intensiva [online]. 2010, vol.34, n.7, pp.483-487. ISSN 0210-5691.

Metformin is an oral biguanide widely used in the management of patients with type 2 diabetes. It produces non-specific gastrointestinal symptoms in 10-30% of the patients. Lactic acidosis is the most serious side effect, so it must not be administered to patients with renal, liver, or heart insufficiency. Only a few cases of hepatotoxicity due to this drug have been documented. We report the case of a patient with type 2 diabetes mellitus and recent use of metformin who developed serious liver injury, followed by a favorable evolution.

Keywords : Metformin; Hepatotoxicity; Idiosyncratic.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License